Results 31 to 39 of about 70 (39)
Some of the next articles are maybe not open access.

Tocilizumab in MOG-antibody spectrum disorder: a case report

Multiple Sclerosis and Related Disorders, 2019
Antonio Uccelli   +2 more
exaly  

Tocilizumab

Reactions Weekly, 2023
openaire   +1 more source

Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab

Neuromuscular Disorders, 2017
Fredrik Piehl, Ritva Pirskanen
exaly  

Tocilizumab

Reactions Weekly, 2011
openaire   +1 more source

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab

Rheumatology, 2010
  +2 more
exaly  

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family

International Immunopharmacology, 2005
Shigeto Kawai   +2 more
exaly  

Tocilizumab: The first interleukin-6-receptor inhibitor

American Journal of Health-System Pharmacy, 2008
exaly  

Update on tocilizumab in rheumatoid arthritis: a narrative review

Frontiers in Immunology
Enrico Fusaro   +2 more
exaly  

Tocilizumab

Reactions Weekly
openaire   +2 more sources
humans
antibodies, monoclonal, humanized
arthritis, rheumatoid
receptors, interleukin-6
3. good health
previous   2  3  4  

Home - About - Disclaimer - Privacy